INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-171378109_pills]( "Factors Affecting Systemic Drug Exposure")
Factors Affecting Systemic Drug ExposureThe increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.
-
![GettyImages-1311429557-vaccine-shot]( "Optimizing Recruitment For Urgently Needed Vaccine")
Optimizing Recruitment For Urgently Needed VaccineUncover how Citeline Connect helped a late-stage biotech sponsor expedite enrollment of a diverse population of eligible patients impacted by monkeypox for a large Phase 1 and Phase 2 trial of a next-generation vaccine.
-
![Beyond Help Desk RTSM Support Ready For Change]( "Beyond Help Desk: RTSM Support Ready For Change")
Beyond Help Desk: RTSM Support Ready For ChangeThis clip explores what sponsors should expect from an RTSM support model built for long‑term study needs, emphasizing capacity, flexibility, and readiness to adapt as trials evolve.
-
![Clinical Leader Solutions Expo]( "Clinical Leader Smart Sourcing Solutions Expo: Retention By Design")
Clinical Leader Smart Sourcing Solutions Expo: Retention By DesignEnhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
How A Complex Personalized Medicine Trial Migrated RTSM Software Without Disruption3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Patient Trust And Engagement In The Age Of Decentralized Trials4/10/2025
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
Clinical Trials Need To Take The Whole Patient Into Account7/10/2025
Explore how inclusivity in clinical trials needs to encompass the whole patient, taking into account factors like race, sex, age, ethnicity, sexual orientation, and physical abilities or qualities.
-
The Scoop On The SCOPE Summit2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
FDA Draft Guidance On Diversity Action Plan Requirements10/24/2024
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-956015576 knee altasciences_edited]( "Selecting The Right Pain Model For Early Phase Analgesic Trials")
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
![GettyImages-1318863581 patient travel]( "Patient Travel And Logistics")
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
![GettyImages-1971327276 doctor patient]( "Balancing The Scales: The Strategic Role Of Stipends In Trial Success")
Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.
-
![patient and doctor iStock-1211396399]( "Special And Patient Populations")
Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.
-
![Patient Satisfaction survey-GettyImages-1356228571]( "Elevating Success: The Crucial Role Of Customer Satisfaction Programs In Companies")
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
